Average Co-Inventor Count = 5.28
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Five Prime Therapeutics, Inc. (10 from 72 patents)
2. Bristol-myers Squibb Compnay (5 from 3,685 patents)
3. Eureka Therapeutics, Inc. (1 from 48 patents)
11 patents:
1. 11566076 - Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for selected cancers
2. 11559583 - Anti-CSF1R antibody and agonistic anti-CD40 antibody combination therapy for cancer
3. 11421034 - Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic cancer
4. 11155615 - Anti-ROR1 antibodies
5. 10982001 - Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)
6. 10975153 - Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)
7. 10822421 - Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)
8. 10618967 - Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer
9. 10221244 - Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer
10. 10221243 - Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)
11. 9765147 - Anti-CSFR1 antibody and anti PD-1 antibody combination therapy for cancer